163 related articles for article (PubMed ID: 16786135)
1. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.
Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G
Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135
[TBL] [Abstract][Full Text] [Related]
2. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
Frosina G
Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
[TBL] [Abstract][Full Text] [Related]
3. Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation.
Hama S; Sadatomo T; Yoshioka H; Kurisu K; Tahara E; Naruse I; Heike Y; Saijo N
Anticancer Res; 1997; 17(3C):1933-8. PubMed ID: 9216647
[TBL] [Abstract][Full Text] [Related]
4. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
5. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity.
Xie QC; Hu YD; Wang LL; Chen ZT; Diao XW; Wang ZX; Guan HJ; Zhu B; Sun JG; Duan YZ; Chen FL; Nian WQ
Colloids Surf B Biointerfaces; 2005 Dec; 46(3):188-96. PubMed ID: 16337111
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic radiation resistance in human chondrosarcoma cells.
Moussavi-Harami F; Mollano A; Martin JA; Ayoob A; Domann FE; Gitelis S; Buckwalter JA
Biochem Biophys Res Commun; 2006 Jul; 346(2):379-85. PubMed ID: 16765318
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapies for malignant gliomas: advances and challenges.
Penas-Prado M; Gilbert MR
Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
[TBL] [Abstract][Full Text] [Related]
10. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
Patel R; Shervington L; Lea R; Shervington A
Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
[TBL] [Abstract][Full Text] [Related]
13. New developments in the treatment of malignant gliomas.
Soffietti R; Leoncini B; Rudà R
Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
[TBL] [Abstract][Full Text] [Related]
14. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
[TBL] [Abstract][Full Text] [Related]
15. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.
Chakravarti A; Dicker A; Mehta M
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):927-31. PubMed ID: 14967452
[TBL] [Abstract][Full Text] [Related]
16. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
Liu ZG; Chen HY; Cheng JJ; Chen ZP; Li XN; Xia YF
Cell Biol Int; 2009 Oct; 33(10):1111-7. PubMed ID: 19664717
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Mori T; Takakura Y
Biochem Biophys Res Commun; 2007 Oct; 362(3):773-8. PubMed ID: 17761140
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for gliomas based on the expression levels of drug resistant genes].
Matsumoto Y; Morisaki K; Miyake K; Kawanishi M; Kawai N; Ogawa T; Irie K; Kunishio K; Nagao S
No Shinkei Geka; 2001 Jul; 29(7):625-30. PubMed ID: 11517503
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of malignant brain gliomas using teniposide].
Mufazalov FF; Sakaeva DD; Shtefan AIu
Vopr Onkol; 2008; 54(2):208-10. PubMed ID: 18522171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
